Preventive Versus Curative Platelet Transfusion Strategies in the Treatment of Acute Myeloid Leukemia Patients: A Comparative Study
Aude Charbonnier(Institut Paoli-Calmettes), Mauricette Michallet(Institut d’Hématologie et d’Oncologie Pédiatrique), Sophie Ducastelle(Hôpital Lyon Sud), L. Augey(Hôpital Lyon Sud), Lilian Laborde(Inserm), Jérémy Monfray(Hôpital Lyon Sud), Thomas Prébet(Yale University), Fiorenza Barraco(Hôpital Lyon Sud), Norbert Vey(Centre de Recherche en Cancérologie de Marseille), Xavier Thomas(Hôpital Lyon Sud), Carine Champigneulle(Hôpital Lyon Sud), Mohamad Sobh(Ottawa Hospital), Franck E. Nicolini(Hôpital Lyon Sud), Jérôme Rey, Michel Raba(Établissement Français du Sang), Anne Etienne(Aix-Marseille Université), Evelyne D’Incan(Institut Paoli-Calmettes), Hélène Labussière‐Wallet, Patrick Ladaique(Institut Paoli-Calmettes)
Cited by 1
Related Papers
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
|The Lancet|2012|1k
Should Adolescents With Acute Lymphoblastic Leukemia Be Treated as Old Children or Young Adults? Comparison of the French FRALLE-93 and LALA-94 Trials
|Journal of Clinical Oncology|2003|606
Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study
|Journal of Clinical Oncology|2009|562
Outcome of Treatment in Adults With Acute Lymphoblastic Leukemia: Analysis of the LALA-94 Trial
|Journal of Clinical Oncology|2004|547
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
|Journal of Clinical Oncology|2013|543